Edition:
United Kingdom

Alpine Immune Sciences Inc (ALPN.OQ)

ALPN.OQ on NASDAQ Stock Exchange Global Market

7.88USD
26 Apr 2018
Change (% chg)

$-0.17 (-2.11%)
Prev Close
$8.05
Open
$8.05
Day's High
$8.26
Day's Low
$7.88
Volume
1,851
Avg. Vol
4,998
52-wk High
$12.82
52-wk Low
$7.30

Latest Key Developments (Source: Significant Developments)

Alpine Immune Sciences Provides Corporate Update And Reports Full Year 2017 Financial Results
Wednesday, 28 Mar 2018 

March 28 (Reuters) - Alpine Immune Sciences Inc ::ALPINE IMMUNE SCIENCES PROVIDES CORPORATE UPDATE AND REPORTS FULL YEAR 2017 FINANCIAL RESULTS.ALPINE IMMUNE SCIENCES - EXPECTS TO HAVE CASH TO FUND OPERATIONS INTO 2020, INCLUDING CLINICAL ADVANCEMENT OF ITS LEAD PROGRAMS ALPN-101 AND ALPN-202.  Full Article

Alpine Immune Sciences qtrly earnings per share ‍$0.18​
Monday, 13 Nov 2017 

Nov 13 (Reuters) - Alpine Immune Sciences Inc ::Alpine Immune Sciences reports corporate update and third quarter 2017 financial results.Q3 revenue $100,000 versus $700,000.Alpine Immune Sciences Inc - ‍company expects to have cash to fund operations into 2020​.Alpine Immune Sciences Inc qtrly earnings per share ‍$0.18​.  Full Article

Nivalis Q2 loss per share $0.55
Monday, 1 Aug 2016 

Nivalis Therapeutics Inc : Q2 loss per share $0.55 . Nivalis therapeutics reports second quarter 2016 financial results .Q2 earnings per share view $-0.52 -- Thomson Reuters I/B/E/S.  Full Article

Nivalis Therapeutics files for mixed shelf of up to $142.5 mln - SEC filing
Wednesday, 6 Jul 2016 

Nivalis Therapeutics Inc : Says files for mixed shelf of up to $142.5 million - SEC filing Source:(http://bit.ly/29xPQCz ) Further company coverage: [NVLS.O] (Bengaluru Newsroom: +1 646 223 8780).  Full Article

BRIEF-Alpine Immune Sciences Appoints Chris Peetz To Its Board

* ALPINE IMMUNE SCIENCES APPOINTS LIFE SCIENCES EXECUTIVE CHRIS PEETZ TO ITS BOARD OF DIRECTORS Source text for Eikon: Further company coverage: